Receptors, Phospholipase A2
"Receptors, Phospholipase A2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that bind to and internalize SECRETED PHOSPHOLIPASES A2. Although primarily acting as scavenger receptors, these proteins may also play a role in intracellular signaling. Soluble forms of phospholipase A2 receptors occur through the action of proteases and may a play a role in the inhibition of extracellular phospholipase activity.
Concept/Terms
Receptors, Phospholipase A2- Receptors, Phospholipase A2
- Receptor, Phospholipase A2
- PLA(2) Receptor
- Phospholipase A2 Receptor
- Phospholipase A2 Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Phospholipase A2".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Phospholipase A2".
This graph shows the total number of publications written about "Receptors, Phospholipase A2" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Phospholipase A2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2019 | 3 | 1 | 4 |
2020 | 0 | 2 | 2 |
2021 | 1 | 3 | 4 |
2022 | 0 | 1 | 1 |
2023 | 0 | 3 | 3 |
Below are the most recent publications written about "Receptors, Phospholipase A2" by people in Profiles.
-
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int. 2023 12; 104(6):1092-1102.
-
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series. Am J Kidney Dis. 2024 Mar; 83(3):340-349.e1.
-
An Unusual Case of Anti-Glomerular Basement Membrane Disease and Phospholipase A2 Receptor-Associated Membranous Nephropathy After Exposure to Hydrocarbons. Am J Kidney Dis. 2024 Jan; 83(1):112-115.
-
Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature. J Nephrol. 2023 03; 36(2):281-283.
-
Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas. Clin J Am Soc Nephrol. 2021 11; 16(11):1730-1742.
-
Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up. Am J Kidney Dis. 2021 12; 78(6):793-803.
-
Podocytic Infolding Glomerulopathy in a Patient with Phospholipase A2 Receptor-Positive Membranous Nephropathy and Review of the Literature. Nephron. 2021; 145(5):496-502.
-
Takayasu's arteritis and secondary membranous nephropathy: an exceptional association. BMJ Case Rep. 2021 Mar 01; 14(3).
-
Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy. Ren Fail. 2020 Nov; 42(1):966-968.
-
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat Commun. 2020 03 30; 11(1):1600.